Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluLaval TR vs Fluarix Immunogenicity and Safety in Adults
NCT00380211Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluzone Trivalent in influenza, sponsored by GSK. Started Sep 2006; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00380211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380211.